Published in Medicine and Law Weekly, December 30th, 2005
"Acacia's revenue growth in 2005 is primarily being driven by new licensing programs for patented technologies that we acquired this year," commented Paul Ryan, chairman and CEO of Acacia.
"The PACS technology is the 32nd patented technology that we have acquired this year. We plan to continue acquiring new patent portfolios as we move more toward our...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medicine and Law Weekly